MoonLake Immunotherapeutics: Form 8-K, filed Dec 3, 2021
Filed with the SEC on Dec 3, 2021 and accepted by EDGAR at Dec 3, 2021, 16:04 ET.
Items reported
- Item 4.02 Non-reliance on financial statements
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-21-063323. Last ingested by Listed: Nov 4, 2026, 07:34 ET. Listed shows no prices and gives no investment advice.